Correlation between P2X7 receptor gene polymorphisms and gout

被引:22
|
作者
Gong, Qiong-yao [1 ,2 ]
Chen, Yong [1 ]
机构
[1] Ningbo 2 Hosp, Dept Rheumatol, Ningbo 315010, Zhejiang, Peoples R China
[2] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China
关键词
Gout; P2X7; receptor; Single-nucleotide polymorphisms; HUMAN P2X(7) RECEPTOR; IL-1-BETA SECRETION; OF-FUNCTION; ARTHRITIS; INTERLEUKIN-1; INFLAMMASOME; LYMPHOCYTES; MECHANISMS; CHANNELS; RELEASE;
D O I
10.1007/s00296-015-3258-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Not all patients with hyperuricemia will develop acute gouty arthritis, indicating that other initiating factors need to be considered. The P2X7 receptor is an adenosine triphosphate-gated nonselective cation channel that has also been suggested to be a proinflammatory receptor. In the immune system, the P2X7 receptor is involved in the processing and release of various proinflammatory cytokines, including interleukin-1 beta (IL-1 beta), IL-18 and tumor necrosis factor-alpha (TNF-alpha). IL-1 beta is a central cytokine in the initiation of the acute inflammatory response, which plays a key role in the pathogenesis of gout and the pathology of acute gouty arthritis. This review will explore single-nucleotide polymorphisms in the P2X7R gene [including rs1718119 (Ala348Thr), rs208294 (His155Tyr), rs3751143 (Glu496Ala), rs28360457 (Arg307Gln) and rs2230911 (Thr357Ser)] and their correlation with the incidence of gout. We conclude that P2X7R gene polymorphisms impact the secretion of IL-1 beta and thus play a vital role in the pathogenesis of gout.
引用
收藏
页码:1307 / 1310
页数:4
相关论文
共 50 条
  • [31] P2X7 polymorphisms and stem cell mobilisation
    Koldej, Rachel
    Collins, Jenny
    Ritchie, David
    LEUKEMIA, 2018, 32 (12) : 2724 - 2726
  • [32] P2X7 polymorphisms and stem cell mobilisation
    Rachel Koldej
    Jenny Collins
    David Ritchie
    Leukemia, 2018, 32 : 2724 - 2726
  • [33] The P2X7 carboxyl tail is a regulatory module of P2X7 receptor channel activity
    Becker, Daniel
    Woltersdorf, Ronja
    Boldt, Wolfgang
    Schmitz, Stephan
    Braam, Ursula
    Schmalzing, Gurnther
    Markwardt, Fritz
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (37) : 25725 - 25734
  • [34] Targeting the P2X7 receptor in rheumatoid arthritis: biological rationale for P2X7 antagonism
    McInnes, I. B.
    Cruwys, S.
    Bowers, K.
    Braddock, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : 878 - 882
  • [35] Associations Between the Purinergic Receptor P2X7 and Leprosy Disease
    Souza, Rebeka da Conceicao
    de Souza, Thais Louvain
    Ferreira, Cristina dos Santos
    Nascimento, Leticia Silva
    Nahn, Edilbert Pellegrini
    Peixoto-Rangel, Alba Lucinia
    FRONTIERS IN GENETICS, 2021, 12
  • [36] P2X7 receptor polymorphisms and susceptibility to tuberculosis in a North Indian Punjabi population
    Chaudhary, A.
    Singh, J. P.
    Sehajpal, P. K.
    Sarin, B. C.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (08) : 884 - +
  • [37] The P2X7 receptor as a therapeutic target
    Romagnoli, Romeo
    Baraldi, Pier Giovanni
    Cruz-Lopez, Olga
    Lopez-Cara, Carlota
    Preti, Delia
    Borea, Pier Andrea
    Gessi, Stefania
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (05) : 647 - 661
  • [38] P2X7 receptor at the heart of disease
    Vasileiou, Ei
    Montero, R. M.
    Turner, C. M.
    Vergoulas, G.
    HIPPOKRATIA, 2010, 14 (03) : 155 - 163
  • [39] P2X7 Receptor as a Therapeutic Target
    De Marchi, Elena
    Orioli, Elisa
    Dal Ben, Diego
    Adinolfi, Elena
    ION CHANNELS AS THERAPEUTIC TARGETS, PT B, 2016, 104 : 39 - 79
  • [40] P2X7 receptor and macrophage function
    Wewers, Mark D.
    Sarkar, Anasuya
    PURINERGIC SIGNALLING, 2009, 5 (02) : 189 - 195